Literature DB >> 3261520

MR imaging of primary tumors of trigeminal nerve and Meckel's cave.

W T Yuh1, D C Wright, T J Barloon, D H Schultz, Y Sato, C A Cervantes.   

Abstract

MR imaging features of 11 primary tumors of the trigeminal nerve and Meckel's cave were analyzed. The tumors consisted of two trigeminal schwannomas, five meningiomas, one lipoma, and three epidermoid tumors. The trigeminal schwannomas had homogeneously decreased signal intensity on T1-weighted images and increased signal intensity on T2-weighted images. Three of the five meningiomas had signal intensity similar to that of surrounding brain on both T1- and T2-weighted images. One meningioma had decreased signal intensity on T1-weighted images and increased signal intensity on T2-weighted images. The other had relatively low signal intensity on both T1- and T2-weighted images owing to heavy calcification demonstrated on CT. The lipoma had homogeneous signal intensity that was isointense with orbital and subcutaneous fat on both T1- and T2-weighted images. The epidermoid tumors had decreased signal intensity on T1-weighted images and markedly increased signal intensity on T2-weighted images. In addition, the epidermoids had an insinuating growth pattern and minimal mass effect. The extent of involvement in the trigeminal nerve distribution was well demonstrated in each case. Because of its multiplanar capability, exquisite anatomic detail, and characteristic tissue signal intensity, we conclude that MR is helpful in the differential diagnosis of primary tumors of the trigeminal nerve and Meckel's cave and in the evaluation of tumor involvement for preoperative planning.

Entities:  

Mesh:

Year:  1988        PMID: 3261520     DOI: 10.2214/ajr.151.3.577

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

1.  MRI of trigeminal neuralgia: initial clinical results in patients with vascular compression of the trigeminal nerve.

Authors:  M A Sens; H P Higer
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

2.  Trigeminal neuromas: assessment of MRI and CT.

Authors:  C Beges; M P Revel; A Gaston; P Brugières; J F Meder; N Martin
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  Metastatic involvement of the Meckel's cave and trigeminal nerve. A case report.

Authors:  L Mastronardi; P Lunardi; J Osman Farah; F Puzzilli
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

4.  Lipoma of trigeminal nerve in a patient with severe trigeminal neuralgia.

Authors:  Jyoti Sureka; Sanuj Panwar; Ravi Kanth Jakkani
Journal:  Neurol Clin Pract       Date:  2011-12

5.  Atypical cystic meningioma of the trigeminal nerve in a pediatric patient.

Authors:  K Obeng; Z Rumboldt; G Tuite; C T Welsh; S Patel; M V Spampinato
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-16       Impact factor: 3.825

6.  Mandibular nerve: MR versus CT about 10 proved unusual tumors.

Authors:  K Marsot-Dupuch; F Matozza; M M Firat; A T Iyriboz; F Chabolle; J M Tubiana
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

7.  Frontotemporal epidural approach to trigeminal neurinomas.

Authors:  V V Dolenc
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Multicompartmental Trigeminal Schwannomas: Dumbbell Tumors Revisited.

Authors:  Abhishek Mahajan; Nilesh P Sable; Richa Vaish; Aliasgar Moiyadi; Supreeta Arya; Anil Keith D'Cruz
Journal:  J Glob Oncol       Date:  2016-07-27

9.  Diffuse large B cell lymphoma involving Meckel's cave masquerading as biopsy-negative giant cell arteritis: a case report.

Authors:  Matthew J Samec; Andres G Madrigal; Charlotte H Rydberg; Matthew J Koster
Journal:  J Med Case Rep       Date:  2020-05-10

10.  Endoscopic Endonasal Resection of Meckel's Cave Epidermoid Cysts: Case Discussion and Literature Review.

Authors:  Jehad Zakaria; Pravesh Saini; Mariya Yanovskaya; John T Tsiang; Krishnan Ravindran; Stephen Johans; Chirag R Patel; Anand V Germanwala
Journal:  Case Rep Neurol Med       Date:  2020-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.